Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G

One of the main challenges in liver cell therapy (LCT) is the induction of a tolerogenic microenvironment to promote graft acceptance in the recipient. Little is known about the immunomodulatory potential of the hepatic cells used in liver cell therapy. In this work, we wanted to evaluate the immuno...

Full description

Saved in:
Bibliographic Details
Main Authors: Catherine A. Lombard, Gwenaëlle Sana, Joël LeMaoult, Mehdi Najar, Joachim Ravau, Floriane André, Fatima Bouhtit, Marina Daouya, Maria Loustau, Mustapha Najimi, Laurence Lagneaux, Edgardo D. Carosella, Etienne M. Sokal
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2019/8250584
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850166828610879488
author Catherine A. Lombard
Gwenaëlle Sana
Joël LeMaoult
Mehdi Najar
Joachim Ravau
Floriane André
Fatima Bouhtit
Marina Daouya
Maria Loustau
Mustapha Najimi
Laurence Lagneaux
Edgardo D. Carosella
Etienne M. Sokal
author_facet Catherine A. Lombard
Gwenaëlle Sana
Joël LeMaoult
Mehdi Najar
Joachim Ravau
Floriane André
Fatima Bouhtit
Marina Daouya
Maria Loustau
Mustapha Najimi
Laurence Lagneaux
Edgardo D. Carosella
Etienne M. Sokal
author_sort Catherine A. Lombard
collection DOAJ
description One of the main challenges in liver cell therapy (LCT) is the induction of a tolerogenic microenvironment to promote graft acceptance in the recipient. Little is known about the immunomodulatory potential of the hepatic cells used in liver cell therapy. In this work, we wanted to evaluate the immunosuppressive properties of human hepatocytes and adult-derived human liver stem/progenitor cells (ADHLSCs), as well as the potential involvement of the immunomodulatory molecule HLA-G. We demonstrated that both cell types were capable of inhibiting the proliferative response of PBMCs to an allogenic stimulus and that the immune inhibitory potential of ADHLSCs, although lower than that of hepatocytes, increased after hepatogenic differentiation. We demonstrated that liver cells express HLA-G and that the immune inhibition pattern was clearly associated to its expression. Interestingly, HLA-G expression increased after the third step of differentiation, wherein oncostatin M (OSM) was added. A 48 hr treatment with OSM was sufficient to induce HLA-G expression in ADHLSCs and result in immune inhibition. Surprisingly, blocking HLA-G partially reversed the immune inhibition mediated by hepatocytes and differentiated ADHLSCs, but not that of undifferentiated ADHLSCs, suggesting that additional immune inhibitory mechanisms may be used by these cells. In conclusion, we demonstrated that both hepatocytes and ADHLSCs present immunomodulatory properties mediated, at least in part, through HLA-G, which can be upregulated following hepatogenic differentiation or liver cell pretreatment with OSM. These observations open up new perspectives for the induction of tolerance following LCT and for potential therapeutic applications of these liver cells.
format Article
id doaj-art-dab643f5b2ef41f79d4dcdc7b9bc1b97
institution OA Journals
issn 2314-8861
2314-7156
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-dab643f5b2ef41f79d4dcdc7b9bc1b972025-08-20T02:21:20ZengWileyJournal of Immunology Research2314-88612314-71562019-01-01201910.1155/2019/82505848250584Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-GCatherine A. Lombard0Gwenaëlle Sana1Joël LeMaoult2Mehdi Najar3Joachim Ravau4Floriane André5Fatima Bouhtit6Marina Daouya7Maria Loustau8Mustapha Najimi9Laurence Lagneaux10Edgardo D. Carosella11Etienne M. Sokal12Laboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain & Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, BelgiumLaboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain & Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, BelgiumService de Recherches en Hémato-Immunologie, CEA-DSV-DRM, Hôpital Saint-Louis, IUH, Avenue Claude Vellefaux 1, 75010 Paris, FranceOsteoarthritis Research Unit, Department of Medicine, University of Montreal Hospital Research Center (CRCHUM), 900 rue Saint-Denis, R11.424, Montreal, QC, H2X 0A9, CanadaLaboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain & Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, BelgiumLaboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain & Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, BelgiumLaboratory of Clinical Cell Therapy, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Campus Erasme, Brussels, BelgiumService de Recherches en Hémato-Immunologie, CEA-DSV-DRM, Hôpital Saint-Louis, IUH, Avenue Claude Vellefaux 1, 75010 Paris, FranceService de Recherches en Hémato-Immunologie, CEA-DSV-DRM, Hôpital Saint-Louis, IUH, Avenue Claude Vellefaux 1, 75010 Paris, FranceLaboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain & Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, BelgiumLaboratory of Clinical Cell Therapy, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Campus Erasme, Brussels, BelgiumService de Recherches en Hémato-Immunologie, CEA-DSV-DRM, Hôpital Saint-Louis, IUH, Avenue Claude Vellefaux 1, 75010 Paris, FranceLaboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain & Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, BelgiumOne of the main challenges in liver cell therapy (LCT) is the induction of a tolerogenic microenvironment to promote graft acceptance in the recipient. Little is known about the immunomodulatory potential of the hepatic cells used in liver cell therapy. In this work, we wanted to evaluate the immunosuppressive properties of human hepatocytes and adult-derived human liver stem/progenitor cells (ADHLSCs), as well as the potential involvement of the immunomodulatory molecule HLA-G. We demonstrated that both cell types were capable of inhibiting the proliferative response of PBMCs to an allogenic stimulus and that the immune inhibitory potential of ADHLSCs, although lower than that of hepatocytes, increased after hepatogenic differentiation. We demonstrated that liver cells express HLA-G and that the immune inhibition pattern was clearly associated to its expression. Interestingly, HLA-G expression increased after the third step of differentiation, wherein oncostatin M (OSM) was added. A 48 hr treatment with OSM was sufficient to induce HLA-G expression in ADHLSCs and result in immune inhibition. Surprisingly, blocking HLA-G partially reversed the immune inhibition mediated by hepatocytes and differentiated ADHLSCs, but not that of undifferentiated ADHLSCs, suggesting that additional immune inhibitory mechanisms may be used by these cells. In conclusion, we demonstrated that both hepatocytes and ADHLSCs present immunomodulatory properties mediated, at least in part, through HLA-G, which can be upregulated following hepatogenic differentiation or liver cell pretreatment with OSM. These observations open up new perspectives for the induction of tolerance following LCT and for potential therapeutic applications of these liver cells.http://dx.doi.org/10.1155/2019/8250584
spellingShingle Catherine A. Lombard
Gwenaëlle Sana
Joël LeMaoult
Mehdi Najar
Joachim Ravau
Floriane André
Fatima Bouhtit
Marina Daouya
Maria Loustau
Mustapha Najimi
Laurence Lagneaux
Edgardo D. Carosella
Etienne M. Sokal
Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G
Journal of Immunology Research
title Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G
title_full Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G
title_fullStr Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G
title_full_unstemmed Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G
title_short Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G
title_sort human hepatocytes and differentiated adult derived human liver stem progenitor cells display in vitro immunosuppressive properties mediated at least in part through the nonclassical hla class i molecule hla g
url http://dx.doi.org/10.1155/2019/8250584
work_keys_str_mv AT catherinealombard humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT gwenaellesana humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT joellemaoult humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT mehdinajar humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT joachimravau humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT florianeandre humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT fatimabouhtit humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT marinadaouya humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT marialoustau humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT mustaphanajimi humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT laurencelagneaux humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT edgardodcarosella humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag
AT etiennemsokal humanhepatocytesanddifferentiatedadultderivedhumanliverstemprogenitorcellsdisplayinvitroimmunosuppressivepropertiesmediatedatleastinpartthroughthenonclassicalhlaclassimoleculehlag